Wegovy, to be in pharmacies by the end of June, has been launched in a pen-injection format with strengths ranging from 0.25 mg to 2.4 mg ...

Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...

Novo Nordisk is planning a major India launch of its blockbuster weight-loss drug Wegovy, aiming for Rs 8,600 crore in sales within 5–7 years. The company eyes top spot in prescription drug sales with ...

MUMBAI -- Danish pharmaceutical major Novo Nordisk on Tuesday launched its Wegovy weight loss drug in India, debuting the medicine ahead of schedule and just months after American rival Eli Lilly ...

Key Takeaways Weighted vests don’t appear to help seniors maintain their bone density while losing weightSeniors wore the ...

Mounjaro has been approved for both type 2 diabetes and weight loss; however, access will be limited by strict eligibility ...

An experimental muscle-preserving drug called bimagrumab helped people taking semaglutide (Ozempic/Wegovy) keep their muscle ...

Danish pharma giant Novo Nordisk on Tuesday launched its blockbuster weight loss drug Wegovy as a once-a-week injection in ...

WEIGHT loss jabs may also help ward off dementia, a new study suggests. Researchers found that semaglutide – the active ...

A GP shares her journey using using GLP-1 medication as primary care prescribing of tirzepatide for obesity begins this week.

In a statement, Novo Nordisk said that it was terminating the collaboration "due to concerns about their illegal mass ...